Stève Bénard

1.2k total citations
45 papers, 837 citations indexed

About

Stève Bénard is a scholar working on Epidemiology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stève Bénard has authored 45 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 11 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stève Bénard's work include Cervical Cancer and HPV Research (11 papers), Genital Health and Disease (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Stève Bénard is often cited by papers focused on Cervical Cancer and HPV Research (11 papers), Genital Health and Disease (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Stève Bénard collaborates with scholars based in France, United States and Germany. Stève Bénard's co-authors include J. Gabrielle Breugelmans, Aurélie Schmidt, Nathalie Largeron, Ruth E. Brown, Peter Hillemanns, S. Bouée, Evan R. Myers, Shalini Kulasingam, Ruanne V. Barnabas and Éric Vicaut and has published in prestigious journals such as PLoS ONE, Critical Care Medicine and The Annals of Thoracic Surgery.

In The Last Decade

Stève Bénard

42 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stève Bénard France 17 455 294 215 104 84 45 837
Joni K. Evans United States 11 218 0.5× 192 0.7× 109 0.5× 22 0.2× 139 1.7× 38 897
H. Gil France 11 271 0.6× 59 0.2× 150 0.7× 103 1.0× 82 1.0× 47 628
Salik Nazir United States 16 197 0.4× 294 1.0× 114 0.5× 26 0.3× 20 0.2× 110 828
Anders Seppä Finland 9 429 0.9× 112 0.4× 133 0.6× 47 0.5× 21 0.3× 16 704
Thomas M. Harrington United States 20 152 0.3× 439 1.5× 214 1.0× 41 0.4× 82 1.0× 51 1.1k
Alden Doyle United States 17 299 0.7× 238 0.8× 102 0.5× 186 1.8× 180 2.1× 51 1.0k
Owen Johnson United States 14 96 0.2× 216 0.7× 140 0.7× 89 0.9× 9 0.1× 28 591
Fouad Madhi France 15 236 0.5× 220 0.7× 174 0.8× 19 0.2× 40 0.5× 57 746
Manuela Albisetti Switzerland 23 225 0.5× 505 1.7× 279 1.3× 39 0.4× 25 0.3× 92 1.6k
T. Pruett United States 15 342 0.8× 293 1.0× 59 0.3× 57 0.5× 88 1.0× 26 766

Countries citing papers authored by Stève Bénard

Since Specialization
Citations

This map shows the geographic impact of Stève Bénard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stève Bénard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stève Bénard more than expected).

Fields of papers citing papers by Stève Bénard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stève Bénard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stève Bénard. The network helps show where Stève Bénard may publish in the future.

Co-authorship network of co-authors of Stève Bénard

This figure shows the co-authorship network connecting the top 25 collaborators of Stève Bénard. A scholar is included among the top collaborators of Stève Bénard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stève Bénard. Stève Bénard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Renaud, Stéphane, M. Chartier, Anne-Françoise Gaudin, et al.. (2025). Epidemiology, patient management, and survival outcomes in resected patients with non-metastatic non-small cell lung cancer: a nationwide real-world study. BMC Cancer. 25(1). 966–966. 2 indexed citations
2.
Monard, Céline, et al.. (2023). Economic burden of in-hospital AKI: a one-year analysis of the nationwide French hospital discharge database. BMC Nephrology. 24(1). 343–343. 11 indexed citations
3.
Sevin, Caroline, et al.. (2023). Childhood cerebral adrenoleukodystrophy (CCALD) in France: epidemiology, natural history, and burden of disease - A population-based study. Orphanet Journal of Rare Diseases. 18(1). 238–238. 2 indexed citations
4.
Brousse, Valentine, et al.. (2023). Severity and burden of sickle cell disease in France: a nationwide realworld study. Haematologica. 108(9). 2476–2486. 13 indexed citations
5.
Rouprêt, Morgan, M. Chartier, Anne-Françoise Gaudin, et al.. (2023). Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study. World Journal of Urology. 41(4). 1069–1075. 4 indexed citations
6.
Gaujoux-Viala, C., et al.. (2023). Suboptimal management of rheumatoid arthritis in France: a real-world study based on data from the French National Health Data System. RMD Open. 9(4). e003075–e003075. 2 indexed citations
7.
8.
Rycke, Yann De, Florence Tubach, Alexandre Lafourcade, et al.. (2020). Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France. PLoS ONE. 15(2). e0228660–e0228660. 10 indexed citations
9.
10.
Abramowitz, Laurent, Jean Lacau Saint Guily, Micheline Moyal‐Barracco, et al.. (2018). Epidemiological and economic burden of potentially HPV-related cancers in France. PLoS ONE. 13(9). e0202564–e0202564. 17 indexed citations
11.
Abramowitz, Laurent, M. Moyal‐Barracco, Nathalie Largeron, et al.. (2016). Epidemiology, Treatment Pathways and Costs of Cancers Potentially Related to HPV Infection in France. Value in Health. 19(7). A609–A610. 1 indexed citations
12.
Bénard, Stève, et al.. (2016). Nintedanib Cost-Utility In Idiopathic Pulmonary Fibrosis In France. Value in Health. 19(7). A556–A556. 2 indexed citations
13.
Schmidt, Aurélie, Stève Bénard, & Sonya Cyr. (2015). Hospital Cost of Staphylococcal Infection after Cardiothoracic or Orthopedic Operations in France: A Retrospective Database Analysis. Surgical Infections. 16(4). 428–435. 24 indexed citations
14.
Bénard, Stève, et al.. (2015). Lifetime cost of meningococcal disease in France: Scenarios of severe meningitis and septicemia with purpura fulminans. Journal of Infection and Public Health. 9(3). 339–347. 16 indexed citations
15.
Cottin, Vincent, et al.. (2015). Idiopathic Pulmonary Fibrosis: Hospital Disease Management and Associated Costs. Value in Health. 18(7). A665–A665. 1 indexed citations
16.
Brillet, G, et al.. (2015). Hospital Costs Of Contrast-Induced Nephropathy. Value in Health. 18(7). A510–A510. 4 indexed citations
17.
Rivera, Caroline, Aurélie Schmidt, Julien Mazières, et al.. (2012). Parcours de soins des patients atteints de cancer bronchique traités chirurgicalement. Revue des Maladies Respiratoires. 30(7). 529–536.
18.
Kulasingam, Shalini, Stève Bénard, Ruanne V. Barnabas, Nathalie Largeron, & Evan R. Myers. (2008). Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: a cost-effectiveness analysis. Cost Effectiveness and Resource Allocation. 6(1). 4–4. 73 indexed citations
19.
Hillemanns, Peter, J. Gabrielle Breugelmans, Friederike Gieseking, et al.. (2008). Estimation of the incidence of genital warts and the cost of illness in Germany: A cross-sectional study. BMC Infectious Diseases. 8(1). 76–76. 80 indexed citations
20.
Monsonégo, Joseph, J. Gabrielle Breugelmans, S. Bouée, et al.. (2007). Incidence, prise en charge et coût des condylomes acuminés anogénitaux chez les femmes consultant leur gynécologue en France. Gynécologie Obstétrique & Fertilité. 35(2). 107–113. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joni K. Evans Breakdown of academic impact, for papers by H. Gil Breakdown of academic impact, for papers by Salik Nazir Breakdown of academic impact, for papers by Anders Seppä Breakdown of academic impact, for papers by Thomas M. Harrington Breakdown of academic impact, for papers by Alden Doyle Breakdown of academic impact, for papers by Owen Johnson Breakdown of academic impact, for papers by Fouad Madhi Breakdown of academic impact, for papers by Manuela Albisetti Breakdown of academic impact, for papers by T. Pruett
Rankless by CCL
2026